Autonomic control of blood pressure in mice: Basic physiology and effects of genetic modification

American Journal of Physiology - Regulatory Integrative and Comparative Physiology

Volumn 282, Issue 6 51-6, 2002, Pages

  Janssen, Ben J A ^a   Smits, Jos F M ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Adrenergic receptors; Autonomic nervous system; Hemodynamic control mechanisms

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR; CATECHOLAMINE; NICOTINIC RECEPTOR;

AUTONOMIC NERVOUS SYSTEM; BLOOD FLOW; BLOOD PRESSURE REGULATION; CATECHOLAMINE BLOOD LEVEL; DNA MODIFICATION; ELECTROCARDIOGRAM; GENOME; HEART OUTPUT; HEART RATE VARIABILITY; HEMODYNAMICS; HOMEOSTASIS; HUMAN; MOUSE; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0036084815     PISSN: 03636119     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpregu.00714.2001     Document Type: Review

References (234)

1. Increased central AT(1)-receptor activation, not systemic vasopressin, sustains hypertension in ANP knockout mice
2. Effect of high salt intake in mutant mice lacking bradykinin-B2 receptors
3. 2A-adrenergic receptor knockout mice
4. β-adrenergic receptor blockade arrests myocyte damage and preserves cardiac function in the transgenic G(sα) mouse
5. The neuronal norepinephrine transporter in experimental heart failure: Evidence for a posttranscriptional downregulation
6. Microsphere and dilution techniques for the determination of blood flows and volumes in conscious mice
7. Hemodynamics in transgenic mice with overexpression of atrial natriuretic factor
8. Release and elimination of dopamine in vivo in mice lacking the dopamine transporter: Functional consequences
9. A targeted disruption in connexin 40 leads to distinct atrioventricular conduction defects
10. Myocardial-directed overexpression of the human β(1)-adrenergic receptor in transgenic mice
11. The mouse genome database (MGD): Expanding genetic and genomic resources for the laboratory mouse
12. Hypothalamic adrenergic receptor changes in the metabolic syndrome of genetically obese (ob/ob) mice
13. Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice
14. Influence of castration and testosterone propionate on cardiac output, renal blood flow, and blood volume in mice
15. 1 receptor-deficient mice
16. Comparison of cardiorespiratory reflexes in NK1 receptor knockout, heterozygous and wild-type mice in vivo
17. Long-term telemetric measurement of cardiovascular parameters in awake mice: A physiological genomics tool
18. Long-term telemetric recording of arterial pressure and heart rate in mice fed basal and high NaCl diets
19. Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs
20. Impaired nociception and pain sensation in mice lacking the capsaicin receptor
21. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors
22. 1B-adrenergic receptor
23. 1A receptor knockout mouse during normal and volume-expanded conditions
24. 2+ channels in G(i2)α gene knockout mouse hearts
25. Differentiation of brain angiotensin type 1a and 1b receptor mRNAs: A specific effect of dehydration
26. Enhanced contractility and decreased β-adrenergic receptor kinase-1 in mice lacking endogenous norepinephrine and epinephrine
27. Peripheral vagal control of heart rate is impaired in neuronal NOS knockout mice
28. Role of the renin-angiotensin system during alterations of sodium intake in conscious mice
29. Silent α(2C)-adrenergic receptors enable cold-induced vasoconstriction in cutaneous arteries
30. Differential distribution of β-adrenergic receptor subtypes in blood vessels of knockout mice lacking β(1)-or β(2)-adrenergic receptors
31. 2 adrenergic receptor gene
32. Methods for vascular access and collection of body fluids from the laboratory rat
33. Opposing effects of β(1)- and β(2)-adrenergic receptors on cardiac myocyte apoptosis: Role of a pertussis toxin-sensitive G protein
34. Nicotinic receptor function: New perspectives from knockout mice
35. Interactions between phospholamban and β-adrenergic drive may lead to cardiomyopathy and early mortality
36. Rules and guidelines for genetic nomenclature in mice: Excerpted version
37. The brain renin-angiotensin system contributes to the hypertension in mice containing both the human renin and human angiotensinogen transgenes
38. Cardiovascular indexes in the mouse at rest and with exercise: New tools to study models of cardiac disease
39. Cardiovascular phenotyping in mice
40. FGF2 signaling is required for the development of neuronal circuits regulating blood pressure
41. Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice
42. ENaC subunits are molecular components of the arterial baroreceptor complex
43. Transgenic studies of cardiac adrenergic receptor regulation
44. 1-adrenergic receptor transgenic mice
45. Validation of a mouse conductance system to determine LV volume: Comparison to echocardiography and crystals
46. Kidney function in ANF-transgenic mice: Effect of blood volume expansion
47. 7 deficient mice
48. Increased blood pressure in α-calcitonin gene-related peptide/calcitonin gene knockout mice
49. Adenylyl cyclase increases responsiveness to catecholamine stimulation in transgenic mice
50. 3-adrenoceptors in the cardiovascular system
51. Torpor in mice is induced by both leptin-dependent and -independent mechanisms
52. Phenotypic screening for heart rate variability in the mouse
53. Impaired para-sympathetic heart rate control in mice with a reduction of functional G protein βγ-subunits
54. Minimal force-frequency modulation of inotropy and relaxation of in situ murine heart
55. In vivo murine left ventricular pressure-volume relations by miniaturized conductance micromanometry
56. Catechol-O-methyltransferase-deficient mice exhibit sexually dimorphic changes in catecholamine levels and behavior
57. Pronounced pharmacologic deficits in M2 muscarinic acetylcholine receptor knockout mice
58. Increased stress response and β-phenylethylamine in MAOB-deficient mice
59. Cortical and medullary hemodynamics in deoxycorticosterone acetate-salt hypertensive mice
60. 2 receptor-disrupted mice
61. 2 receptor
62. Metabolic flux measurements across portal drained viscera, liver, kidney and hindquarter in mice
63. Alteration of cardiovascular and neuronal function in M1 knockout mice
64. Effects of avertin versus xylazine-ketamine anesthesia on cardiac function in normal mice
65. Overexpression of NGF within the heart of transgenic mice causes hyperinnervation, cardiac enlargement, and hyperplasia of ectopic cells
66. 2-receptors involved in the cardiovascular actions of centrally acting antihypertensive agents
67. Vagal and sympathetic components of the heart rate range and gain of the baroreceptor-heart rate reflex in conscious rats
68. The age-dependent effect of caffeine on the plasma noradrenaline content in white mice
69. 2-adrenergic receptors regulate sympathetic neurotransmission
70. 2-adrenoceptor subtypes in mediating central effects of catecholamines and imidazolines
71. Basal lung mechanics and airway and pulmonary vascular responsiveness in different inbred mouse strains
72. Reduction of chronic psychosocial hypertension in mice by decaffeinated tea
73. Gene targeting reveals a critical role for neuroturin in the development and maintenance of enteric, sensory, and parasympathetic neurons
74. Differential role of melanocortins in mediating leptin's central effects on feeding and reproduction
75. New approaches to phenotypic analysis in adult mice
76. Targeted gene mutation approaches to the study of anxiety-like behavior in mice
77. 2+ release involved in positive inotropic effect mediated by CGRP in ventricular myocytes
78. Plasma catecholamine response to physical and psychological aspects of fighting in mice
79. Ventilatory responses to acute and chronic hypoxia in mice: Effects of dopamine D2 receptors
80. The influence of restraint on blood pressure in the rat
81. Autonomic nervous function in mice and voles (Microtus arvalis): Investigation by power spectral analysis of heart rate variability
82. Heterozygous VMAT2 knockout mice display prolonged QT intervals: Possible contributions to sudden death
83. Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS α overexpression
84. Cardiomyopathy induced by cardiac Gs α overexpression
85. Targeted inactivation of Gα(i) does not alter cardiac function or β-adrenergic sensitivity
86. Chronic measurement of cardiac output in conscious mice
87. Short-term and long-term blood pressure and heart rate variability in the mouse
88. Frequency-dependent modulation of renal blood flow by renal nerve activity in conscious rabbits
89. 1 and β
90. Evidence that decreased heart rate in thyroid hormone receptor-α1-deficient mice is an intrinsic defect
91. Models of experimental hypertension in mice
92. Sympathetic modulation of blood pressure variability
93. Interaction between neuronal nitric oxide synthase and inhibitory G protein activity in heart rate regulation in conscious mice
94. Autonomic cardiovascular control in conscious mice
95. Impaired blood-brain barrier function in angiotensinogen-deficient mice
96. 4-adrenoceptor pharmacology
97. A new method for measuring respiration in the conscious mouse
98. The α(2A) adrenoceptor and the sympathetic postganglionic neuron contribute to the development of neuropathic heat hyperalgesia in mice
99. Effects of antisense oligodeoxynucleotide targeting of the α(2B)-adrenergic receptor messenger RNA in the central nervous system
100. Effects of naloxone, an opiate receptor antagonist, on coxsackievirus B3 myocarditis in the mouse
101. Blunted respiratory responses to hypoxia in mutant mice deficient in nitric oxide synthase-3
102. Targeted disruption of the tyrosine hydroxylase locus results in severe catecholamine depletion and perinatal lethality in mice
103. Functional consequences of altering myocardial adrenergic receptor signaling
104. Cardiac function in mice overexpressing the β-adrenergic receptor kinase or a βARK inhibitor
105. Augmentation of cardiac contractility mediated by the human β(3)-adrenergic receptor overexpressed in the hearts of transgenic mice
106. Circulatory control and the supercontrollers
107. Telemetric monitoring of blood pressure in freely moving mice: A preliminary study
108. A noninvasive computerized tail-cuff system for measuring blood pressure in mice
109. Respiratory mechanics and maximal expiratory flow in the anesthetized mouse
110. Abundant tissue butyrylcholinesterase and its possible function in the acetylcholinesterase knockout mouse
111. Circadian blood pressure and heart rate rhythms in mice
112. Vanilloid receptor-related osmotically activated channel (VR-OAC), a candidate vertebrate osmoreceptor
113. β-adrenergic receptors in the failing heart: The good, the bad, and the unknown
114. Early and delayed consequences of β(2)-adrenergic receptor overexpression in mouse hearts: Critical role for expression level
115. Gata3 loss leads to embryonic lethality due to noradrenaline deficiency of the sympathetic nervous system
116. Renal sympathetic nerve activity in mice: Comparison between mice and rats and between normal and endothelin-1 deficient mice
117. 2-adrenergic receptor subtypes b and c
118. Considerations for the evaluation of renal function in genetically engineered mice
119. The control of microvascular permeability and blood pressure by neutral endopeptidase
120. Mice lacking α-calcitonin gene-related peptide exhibit normal cardiovascular regulation and neuromuscular development
121. A novel effect of angiotensin on renal sympathetic nerve activity in mice
122. Angiotensin selectively activates a subpopulation of postganglionic sympathetic neurons in mice
123. Altered baroreflex control of heart rate in bradykinin B2-receptor knockout mice
124. 2B-adrenergic receptor in the development of salt-induced hypertension
125. Sympathoinhibitory function of the α(2A)-adrenergic receptor subtype
126. Role of α(2)-adrenergic receptor subtypes in the acute hypertensive response to hypertonic saline infusion in anephric mice
127. 1-adrenoceptors
128. Hypertension in β-adducin-deficient mice
129. Nicotinic acetylcholine receptor knockout mice as animal models for studying receptor function
130. Long-term measurement of arterial blood pressure in conscious mice
131. Comparison of arterial blood pressure in different strains of mice
132. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
133. Atrioventricular conduction versus heart size from mouse to whale
134. Renal physiology of the mouse
135. Chronic hypertension and altered baroreflex responses in transgenic mice containing the human renin and human angiotensinogen genes
136. 2-adrenergic receptor
137. Normal blood pressure and renal function in mice lacking the bradykinin b(2) receptor
138. A new method for measurement of blood pressure, heart rate, and activity in the mouse by radiotelemetry
139. Leptin alters metabolic rates before acquisition of its anorectic effect in developing neonatal mice
140. In vivo measurement of lung volumes in mice
141. Angiogenesis in the mouse lung
142. 1 receptors mediate the anorectic action of the pancreatic hormone amylin
143. Upregulation of β(3)-adrenoceptors and altered contractile response to inotropic amines in human failing myocardium
144. 1a receptor
145. Enhanced central response to dehydration in mice lacking angiotensin AT(1a) receptors
146. Intravenous cyclosporine activates afferent and efferent renal nerves and causes sodium retention in innervated kidneys in rats
147. Fulminant hypertension in transgenic rats harbouring the mouse Ren-2 gene
148. Nitric oxide can increase heart rate by stimulating the hyperpolarization-activated inward current, If
149. β-adrenergic axis and heart disease
150. Normal ventilation and ventilatory responses to chemical stimuli in juvenile mutant mice deficient in endothelin-3
151. Motor and learning dysfunction during postnatal development in mice defective in dopamine neuronal transmission
152. Renal function and glucose transport in male and female mice with diet-induced type II diabetes mellitus
153. Postnatal development and progression of renal dysplasia in cyclooxygenase-2 null mice
154. 1C promoter in cardiac myocytes: Role of an MCAT element that binds transcriptional enhancer factor-1 (TEF-1)
155. Elevated sympathetic nervous activity in mice deficient in αCGRP
156. Autonomic control of ultradian and circadian rhythms of blood pressure, heart rate, and baroreflex sensitivity in spontaneously hypertensive rats
157. Cardiovascular and metabolic responses to fasting and thermoneutrality are conserved in obese Zucker rats
158. Cardiovascular neural reflexes in L-NAME-induced hypertension in mice
159. Modulation of cardiovascular control mechanisms and their interaction
160. 1-adrenergic receptors: New insights and directions
161. Altered β-adrenergic receptor gene regulation and signaling in chronic heart failure
162. Salt restriction induces pseudohypoaldosteronism type 1 in mice expressing low levels of the β-subunit of the amiloride-sensitive epithelial sodium channel
163. Leptin effect in ob/ob mice under thermoneutral conditions depends not necessarily on central satiation
164. Important role of endogenous norepinephrine and epinephrine in the development of in vivo pressure-overload cardiac hypertrophy
165. Fluospheres for cardiovascular phenotyping genetically modified mice
166. A five-parameter logistic equation for investigating asymmetry of curvature in baroreflex studies
167. Familial orthostatic tachycardia due to norepinephrine transporter deficiency
168. Orthostatic intolerance and the postural tachycardia syndrome: Genetic and environment pathophysiologies. Neurolab autonomic team
169. Cardiac function in genetically engineered mice with altered adrenergic receptor signaling
170. Physiological consequences of β-adrenergic receptor disruption
171. 2-adrenergic receptors
172. 1-adrenergic receptor knockout mouse
173. 2, a functional neuroturin receptor
174. Cardiac-directed adenylyl cyclase expression improves heart function in murine cardiomyopathy
175. Pain threshold, learning and formation of brain edema in mice lacking the angiotensin II type 2 receptor
176. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo
177. Splanchnic and systemic hemodynamics in mice using radioactive microsphere technique
178. Effect of sleep/wake state on arterial blood pressure in genetically identical mice
179. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis
180. Mechanical ventilation of mice
181. Telemetric monitoring of adrenocorticotropin-induced hypertension in mice
182. Knockout corner: Knockout mice for monoamine oxidase A
183. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency
184. Elevated blood pressures in mice lacking endothelial nitric oxide synthase
185. Genetic variation among 129 substrains and its importance for targeted mutagenesis in mice
186. Of mice and men and elephants: Metabolic rate sets glomerular filtration rate
187. Plasma angiotensin in binephrectomised mice
188. Enhanced blood pressure variability in eNOS knockout mice
189. Physiological insights from genetic manipulation of the renin-angiotensin system
190. Long-term heart rate telemetry in small mammals: A comprehensive approach as a prerequisite for valid results
191. 2C adrenergic receptor immunoreactivity in the rat spinal cord
192. Inactivation of one copy of the mouse neurotrophin-3 gene induces cardiac sympathetic deficits
193. VMAT2 knockout mice: Heterozygotes display reduced amphetamine-conditioned reward, enhanced amphetamine locomotion, and enhanced MPTP toxicity
194. Anesthetic inhibition in ischemic and nonischemic murine heart: Comparison with conscious echocardiographic approach
195. 2B-adrenergic receptor subtypes in brain
196. Restoration of norepinephrine and reversal of phenotypes in mice lacking dopamine β-hydroxylase
197. Impaired maternal behavior in mice lacking norepinephrine and epinephrine
198. Genealogy of the 129 inbred strains: 129/SvJ is a contaminated inbred strain
199. α(2)-adrenergic receptors are not required for central anti-hypertensive action of moxonidine in mice
200. Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsα
201. 2+ channels in mouse heart
202. Direct and indirect methods used to study arterial blood pressure
203. Muscarinic and β-adrenergic regulation of heart rate, force of contraction and calcium current is preserved in mice lacking endothelial nitric oxide synthase
204. β(3)-adrenoceptor deficiency blocks nitric oxide-dependent inhibition of myocardial contractility
205. Electrophysiological features of the mouse sinoatrial node in relation to connexin distribution
206. Measurement of cardiac output in small laboratory animals using recordings of blood conductivity
207. 1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity
208. Chronic inborn erythrocytosis leads to cardiac dysfunction and premature death in mice overexpressing erythropoietin
209. Induction of atrial tachycardia and fibrillation in the mouse heart
210. H(+)-gated cation channels
211. H(+)-gated cation channels: Neuronal acid sensors in the NaC/DEG family of ion channels
212. Altered heart rate and blood pressure variability in mice lacking the Mas protooncogene
213. Trauma-hemorrhage and resuscitation in the mouse: Effects on cardiac output and organ blood flow
214. Compensatory up-regulation of angiotensin II subtype 1 receptors in αENaC knockout heterozygous mice
215. Increased vasodilator responses to acetylcholine in psychosocial hypertensive mice
216. The structure of the mouse heart in late fetal stages
217. Mouse electrocardiography: An interval of thirty years
218. Determination of cardiac output in the mouse
219. Abnormal heart rate regulation in GIRK4 knockout mice
220. Dobutamine-stress magnetic resonance microimaging in mice: Acute changes of cardiac geometry and function in normal and failing murine hearts
221. Developmental changes of cardiac function and mass assessed with MRI in neonatal, juvenile, and adult mice
222. Postnatal developmental delay and supersensitivity to organophosphate in gene-targeted mice lacking acetylcholinesterase
223. Renin-dependent cardiovascular functions and renin-independent blood-brain barrier functions revealed by renin-deficient mice
224. Age-related left ventricular function in the mouse: Analysis based on in vivo pressure-volume relationships
225. Echocardiographic assessment of cardiac function in conscious and anesthetized mice
226. Endothelial nitric oxide gene knockout mice: Cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury
227. Cyclosporine A-induced hypertension involves synapsin in renal sensory nerve endings
228. 2A-adrenoceptor transgenic mice
229. Dual modulation of cell survival and cell death by β(2)-adrenergic signaling in adult mouse cardiac myocytes
230. Hypoalgesia in mice with a targeted deletion of the tachykinin 1 gene
231. Heterotrimeric G proteins in heart disease
232. 1B-adrenergic receptor